Marathon Fusion's high-rate gold alchemy confirmed by...?
As of Sun, 22 Nov 2026 13:00:30 UTC, Polymarket traders price June 30 (18.0%), December 31 (1.3%). The market has $15K in volume and closes on Thu, 01 Jul 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| June 30 | 18.0% | 18.0¢ | 82.0¢ |
| December 31 | 1.3% | 1.3¢ | 98.7¢ |
Market details
- Venue: Polymarket
- Volume: $15K
- Liquidity: $4K
- Closes:
Resolution rules
On October 21, 2026, Marathon Fusion announced that it had "demonstrated high-rate alchemy," turning mercury into stable gold using fusion neutrons and "beating CERN's record by a factor of 10." (see: https://x.com/MarathonFusion/status/2113001073019662481) This market will resolve to "Yes" if high-rate alchemy is confirmed through at least one of the qualifying confirmation methods listed below by 11:59 PM ET on the specified date. Otherwise, this market will resolve to "No". "High-rate alchemy" refers to the experimental production of stable gold-197 from mercury using neutrons generated by deuterium-tritium fusion reactions (including deuterium-tritium neutron generators) at an average rate of more than 800,000 gold-197 atoms per second. For reference, CERN's ALICE collaboration reported a maximum rate of approximately 89,000 gold nuclei per second in May 2025. The production rate will be calculated as the total number of gold-197 atoms produced by the irradiation, including gold-197 resulting from the decay of mercury-197 created during the irradiation, divided by the total duration of the neutron irradiation. Confirmations that only establish that some gold was produced from mercury, that establish a lower production rate, that rely on neutrons not generated by deuterium-tritium fusion reactions, or that are based on simulations or modeling without an experimental demonstration will not qualify. The qualifying confirmation methods are: (i) Peer-reviewed publication:…
Sources
Related markets
- FDA approves Retatrutide this year?
- FDA approves skin cancer vaccine by...?
- Which Millennium Prize Problem will AI solve next?
- SpaceX Starship fully reusable before 2027?
- Which math problems will AI solve in 2026?
- Discord IPO Closing Market Cap
More markets like this
- Will OpenAI rename itself to OpenSI?
- Exponential Time Hypothesis disproof confirmed by...?
- What will Gold (GC) hit__ by end of December?
- What will Gold (XAUUSD) hit in November 2026?
- Meta's Watermelon Model: Humanity's Last Exam Debut?
- Meta's Watermelon Model: Text Arena Debut?
- Muse Charm released by...?
- Muse on Meta glasses by...?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.